Navigation Links
Personality Changes may Help to Identify a Form of Dementia

Dementia with Lewy bodies is the second most widespread neurodegenerative cause of dementia . It shares characteristics with both Alzheimer's and Parkinson's disease. Getting the accurate diagnosis is particularly important because some medications used to treat the mental health symptoms of Alzheimer's disease can be potentially hazardous for people with dementia with Lewy bodies.

The study found that even prior to diagnosis, people with dementia with Lewy bodies showed passive personality changes, such as diminished emotional reaction, indifference to hobbies, repetitive behaviours, and growing apathy, or lack of interest, more often than those with Alzheimer's.

The study involved 290 people who were part of a larger study and were tested every year for an average of about five years. By the end of the study, 128 of the participants had established cases of dementia with Lewy bodies, 128 had Alzheimer's and 34 had no form of dementia.

Researchers followed the participants through death, including autopsy results. During yearly interviews, participants or their family members were asked about changes in personality, interests and drives.

People with dementia with Lewy bodies were two times more prone to have passive personality traits at the time of the first assessment than people with Alzheimer's disease. By the time of death, up to 75 percent of those with dementia with Lewy bodies had passive personality changes compared to 45 percent of those with Alzheimer's disease.

Currently we mainly look for memory problems and other cognitive problems to detect dementia, but personality changes can often occur several years before the cognitive problems.

Identifying the earliest features of dementia may enable doctors to begin therapy as soon as possible. This will become increasingly important as newer, potentially disease-modifying medications are developed. It also gives the patient an
'"/>




Page: 1 2

Related medicine news :

1. Personality Impacts Arthritis
2. Personality profiles of gamblers and substance abusers are similar
3. Negative Effects of Asthma Can Be Countered With Personality changes
4. ADHD Risk Pronounced in Children with Extreme Personality Traits
5. Suicide Attempts Shoot Up Among Alcoholics with Personality Disorder
6. Sound Of Sneezing Could Speak About Ones Personality Traits
7. Personality Disorders Caused Army To Let Go Of 1,000 Soldiers
8. Myth of Type-A-Personality Linked to Heart Disease Busted
9. The Persona of Cancer Affected By Personality?
10. Intensive Psychotherapy Provides Helping Hand in Borderline Personality Disorder.
11. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
Post Your Comments:
(Date:12/2/2008)... CHICAGO, Dec. 2 Breast-Specific ...ly sensitive imaging technique for the diagnosis o...o diagnose breast cancer. BSGI,is a molecular bre...dent of,tissue density and discover very early st...ound and magnetic resonance imaging (MRI), BSGI ha...
(Date:12/2/2008)... PHILADELPHIA, Dec. 2 U...lvania children the opportunity to become "health,... designing programs to,address it and implementin...edHealth HEROES is a service-learning, health lite...e, working through educators and youth,leaders, t...
(Date:12/2/2008)... Money may be better spent in other areas, expert...s) -- Hospital rapid response teams, created to pr...patients, do not seem to work, a new study finds. ...over the past decade," said lead researcher Dr. Pa...t Institute in Kansas City, Mo. "Earlier studies h...
(Date:12/2/2008)... , The Health Story Proje...he project formerly known as “Clinical Docum...(CDA4CDT). CDA4CDT will continue as the label for ...nd submitted to Health Level Seven (HL7) for ballo... (Business Wire EON) December 2, 2008 -- "Ou...
Breaking Medicine News(10 mins):Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2Health News:UnitedHealth Group Grants to Help Students and Educators Combat Childhood Obesity 2Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 2Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5
...led that there has been an increase in heart failu...s are higher among women, // with men surviving f...n the incidence of heart failures during the 1990 ...eriod, in the case of people aged over 65 years, a...
...ent has approved the drug TEMODAL in combination w...astoma multiforme brain cancer. // The drug TEMODA...ng-Plough Corporation and is used in treating two ...forme and anaplastic astrocytoma. Clinical study ...
...to India’s National Institute of Immunology are re...ch helps us to understand how the tuberculosis (TB...ll help in developing newer and more effective med...y as 2 million lives across the world annually. Th...
... the worst possible results does not serve any pur...he disappointment in the end is the same for both ...ttle Pacific University and Jonathon Brown of the ...hnique of ‘defensive pessimism’ and reported their...
Other Medicine News:
(Date:12/2/2008)...c. 2 Horizon Therapeutics, Inc., a...announced that two pivotal,Phase 3 trials evaluat...T-501,met all primary endpoints. HZT-501, a nove...taining ibuprofen and famotidine, demonstrated a,...ce of non-steroidal,anti-inflammatory drug (NSAID...
(Date:12/1/2008)... CHICAGO, Dec. 2 A stu...EM), a new technique for imaging the breast, is no...ormonal status, two factors that limit the effecti...g cancer. Results will be presented today at the a... America (RSNA). , , "The ability of PEM t...
(Date:12/1/2008)...1 S*BIO Pte Ltd today announced th...18, a potent and orally-active JAK2 inhibitor, in ...with chronic idiopathic myelofibrosis (CIMF). , ...ty and tolerability of SB1518 in patients with CIM... Phase 1 part of the study will assess the safety ...
(Date:12/1/2008)...hows the Prox1 gene is a two-way switch that, if t...e reprogrammed so that they lose their identity an..., MEMPHIS, Tenn., Dec. 1 /PRNewswire-USNewswire/...spital have discovered that a certain differentiat...at it requires the constant expression of a gene c...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3JAMA Commentary Opposes Criminal Punishment for HIV Exposure Transmission 6916 1JAMA Commentary Opposes Criminal Punishment for HIV Exposure Transmission 6916 2JAMA Commentary Opposes Criminal Punishment for HIV Exposure Transmission 6916 3Kowa Company Ltd Acquires ProEthic Pharmaceuticals Inc 6913 1Kowa Company Ltd Acquires ProEthic Pharmaceuticals Inc 6913 2Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals 6909 1Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals 6909 2Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals 6909 3Huifeng Bio Pharmaceutical 28HFGB 29 to Release Second Quarter 2008 Earnings Results on August 15 2008 6904 1
...ion during the,early post-operative period compare...ion in nausea in the female,patient population com... CeNeS Pharmaceuticals plc (AIM:,CEN), the Cambrid...tional data from post-hoc analysis of the recent P...nide) in over 500 patients,with post-operative pai...
...0%; mso-hyphenate: none">,BUDAPEST, Hungary, June,...sands of patients with cancer from suffering,unnec...ngress of,the European Association for Palliative ...ated whether this first in class novel,formulation...,duration of effect, mirroring the breakthrough pa...
Other Medicine Technology:Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 2Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 4Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 5Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 6
Inquire
Inquire
...nce, the SZX7 is designed for ease of use and work...ns to advanced research. The SZX7 offers one of th...ding image clarity, true color and accurate reprod...ined detail. System modularity and abundant access...
A compact stereomicroscope that is immediately ready for operation and extremely easy to use. Focused on the essential performance features, the Stemi DV4 design concept provides optimum utility.
Medicine Products: